SEEGENE Trademark

Trademark Overview


On Tuesday, July 6, 2021, a trademark application was filed for SEEGENE with the United States Patent and Trademark Office. The USPTO has given the SEEGENE trademark a serial number of 79323815. The federal status of this trademark filing is REGISTERED as of Tuesday, January 31, 2023. This trademark is owned by SEEGENE, INC.. The SEEGENE trademark is filed in the Computer & Software Services & Scientific Services and Medical & Beauty Services & Agricultural Services categories with the following description:

Pharmaceutical advice; pharmacy advice in the field of preparation of prescriptions in pharmacies; providing medical information relating to diagnostic, prophylactic and therapeutic properties of medical products; providing medical information relating to diagnostic, prophylactic and therapeutic properties of medical products via the Internet; telemedicine services; medical services; medical information services provided via the Internet; medical and pharmaceutical consultation; medical testing services, namely, medical diagnostic testing; medical testing for diagnostic or treatment purposes; medical cancer testing for diagnostic or treatment purposes; genetic testing for medical purposes; healthcare services through the Internet; consulting services in the field of health management in the nature of managing health conditions through the internet; medical clinical pathology examination; health checkup and information services related thereto; medical clinical test in the nature of dia...

Research and development in the field of special testing using genetic engineering; biological services, namely, testing and analysis of biological samples in research laboratories; research and development of DNA chips; structural and functional analysis of genomes; biotechnological research; advisory services relating to biotechnological research; biological research; biochemical analysis; biochemical research; research in the field of gene analysis; genetic research; chemical analysis; research in the field of chemistry; chemical research and analysis; chemical research; research and development of vaccines and medicines; crude drugs research; research on adult diseases; bacteriological research; scientific research for medical purposes in the field of cancerous diseases; research relating to medicines; pharmaceutical products evaluation; consultancy pertaining to pharmacology; testing of pharmaceuticals; pharmaceutical research; medical research; medical science research in the fie...
seegene

General Information


Serial Number79323815
Word MarkSEEGENE
Filing DateTuesday, July 6, 2021
Status700 - REGISTERED
Status DateTuesday, January 31, 2023
Registration Number6966080
Registration DateTuesday, January 31, 2023
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 15, 2022

Trademark Statements


Goods and ServicesPharmaceutical advice; pharmacy advice in the field of preparation of prescriptions in pharmacies; providing medical information relating to diagnostic, prophylactic and therapeutic properties of medical products; providing medical information relating to diagnostic, prophylactic and therapeutic properties of medical products via the Internet; telemedicine services; medical services; medical information services provided via the Internet; medical and pharmaceutical consultation; medical testing services, namely, medical diagnostic testing; medical testing for diagnostic or treatment purposes; medical cancer testing for diagnostic or treatment purposes; genetic testing for medical purposes; healthcare services through the Internet; consulting services in the field of health management in the nature of managing health conditions through the internet; medical clinical pathology examination; health checkup and information services related thereto; medical clinical test in the nature of diagnostic testing and genetic testing for treatment purposes and information services related thereto; providing collected and managed medical information and personal health information; medical screening and examining services for disease prevention of cancer, infectious disease by pathogens and genetic disease by mutation; medical screening and examining services for disease prevention of cancer, infectious disease by pathogens and genetic disease by mutation to improve health culture; healthcare; health counselling; physical examination services; hospital services, not including dentistry services; medical clinic services, not including dentistry services; telemedicine services, not including dentistry services; rental of medical and health care equipment; medical assistance services; medical consultation services, not including dentistry services; medical equipment rental; providing health information services, not including dentistry services; health center services; performing diagnosis of diseases; medical and diagnostic services, namely, identifying hereditary risk factors; medical and medical diagnostic services for disease prevention; medical and diagnostic services, namely, diagnosing in the nature of in vitro diagnostic services for medical purposes; medical analysis services relating to the treatment of persons, namely, analysis of human bodily fluid and tissue samples for diagnostic and treatment services provided by a medical laboratory
Goods and ServicesResearch and development in the field of special testing using genetic engineering; biological services, namely, testing and analysis of biological samples in research laboratories; research and development of DNA chips; structural and functional analysis of genomes; biotechnological research; advisory services relating to biotechnological research; biological research; biochemical analysis; biochemical research; research in the field of gene analysis; genetic research; chemical analysis; research in the field of chemistry; chemical research and analysis; chemical research; research and development of vaccines and medicines; crude drugs research; research on adult diseases; bacteriological research; scientific research for medical purposes in the field of cancerous diseases; research relating to medicines; pharmaceutical products evaluation; consultancy pertaining to pharmacology; testing of pharmaceuticals; pharmaceutical research; medical research; medical science research in the field of clinical pathology and special examination; scientific research in the nature of conducting clinical trials for others; medical research and technical diagnostic testing services for evaluating clinical trial progress; medical research laboratory services for predicting disease; medical laboratory services, namely, preparation and analysis of human body tissue and fluid samples, providing reports respecting the same; research and development of infectious disease diagnosis products; research and development agency of infectious disease diagnosis products; research and development of bacterial and virus test products; research and development agency of bacterial and virus test products; research and development of genetic disease diagnosis products; research and development agency of genetic disease diagnosis products; research and development of blood analysis; research and development agency of blood analysis; research and development agency of cell test products for medical research, treatment, and diagnosis; research and development of cell test products for medical research, treatment, and diagnosis; research and development of body fluid and tissue sample analysis products for medical research, treatment, and diagnosis; research and development agency of body fluid and tissue sample analysis products for medical research, treatment, and diagnosis

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, October 26, 2021
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, October 10, 2022
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameSEEGENE, INC.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressKR

Party NameSEEGENE, INC.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressKR

Party NameSEEGENE, INC.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressKR

Trademark Events


Event DateEvent Description
Tuesday, May 30, 2023FINAL DECISION TRANSACTION PROCESSED BY IB
Thursday, May 4, 2023FINAL DISPOSITION NOTICE SENT TO IB
Thursday, May 4, 2023FINAL DISPOSITION PROCESSED
Sunday, April 30, 2023FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, January 31, 2023NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, January 31, 2023REGISTERED-PRINCIPAL REGISTER
Tuesday, November 15, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 15, 2022PUBLISHED FOR OPPOSITION
Wednesday, October 26, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, October 10, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, October 10, 2022EXAMINER'S AMENDMENT ENTERED
Monday, October 10, 2022NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Monday, October 10, 2022EXAMINERS AMENDMENT E-MAILED
Monday, October 10, 2022EXAMINERS AMENDMENT -WRITTEN
Saturday, September 10, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, September 9, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, September 9, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, June 6, 2022REFUSAL PROCESSED BY IB
Monday, May 16, 2022NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Monday, May 16, 2022REFUSAL PROCESSED BY MPU
Friday, April 1, 2022NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Thursday, March 31, 2022NON-FINAL ACTION WRITTEN
Friday, March 25, 2022ASSIGNED TO EXAMINER
Saturday, October 30, 2021APPLICATION FILING RECEIPT MAILED
Tuesday, October 26, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, October 22, 2021SN ASSIGNED FOR SECT 66A APPL FROM IB